Mouth Ulcers Treatment Market - Global Industry Analysis (2018 - 2020) - Growth Trends and Market Forecast (2021 - 2026)

With the significance of oral health on a consistent surge, oral ulcerations have also been garnering attention worldwide. Predominantly caused among patients with inflammatory bowel diseases, mouth ulcers are also common among oral cancer patients. Higher prevalence of these conditions is thus expected to drive the growth of mouth ulcers treatment market. Moreover, oral herpes cases are typically followed by cold sores in and around mouth, which would further contribute toward market growth. As projected by the latest published report, global mouth ulcers treatment market is poised for steady revenue growth over the forecast period, 2021 - 2026. Toward the end of forecast period, the global market revenue is all set to surpass US$2 Bn.

Key Highlights into Global Mouth Ulcers Treatment Market:

• Between 2021 and 2026, mouth ulcers treatment market will exhibit modest growth of 3.9%
• Analgesics, and corticosteroids continue to represent the most sought-after category throughout the forecast period
• Aphthous stomatitis remains the most common indication generating demand for effective treatment for mouth ulcers
• The market in North America continues to be dominant globally, whereas that in Asia Pacific is poised for the fastest growth rate through 2026
• The US market will especially thrive on the back of the consistent surge in mouthwash sales

Gel Formulations Sought-after

While demand for more effective, and safer yet affordable treatment remains on an upswing for faster cure, patients are more inclined toward spending more on frequent prescriptions, over-the-counter medications, as well as other available treatments. The report reveals continued lead of analgesics, and corticosteroids that are poised for around 4.3% growth. On the other hand, gel formulations continue to capture a major revenue share in global market, reaching the valuation of nearly US$490 Mn by 2026 end. Indication-wise, aphthous stomatitis indication will be the most common one, representing the market valuation of over US$1 Bn in 2026.

North America’s Dominance Intact, Opportunities Abound in Asia Pacific

Research suggests that a significantly large population in the US alone has been using mouthwash on a regular basis, which continues to keep the mouthwash sales afloat across the country. As overuse of mouthwash has been linked to oral ulcerations, demand for mouth ulcers treatment will also most likely remain on an uptrend here, says the report. In addition, millions of new oral cancer cases across the North American region will further uphold its top market positioning. The market here will maintain its sustained growth through 2026 end, exhibiting stable expansion at more than 3% CAGR.

Although North America remains the global leader, Asia Pacific is forecast as the most attractive pocket for investors, and brands. During the period of assessment, Asia Pacific is expected to witness the highest 4.7% growth. A host of opportunities are likely to flock in the region, especially in in China, India, Japan, and South Korea, with a shifting consumer lifestyle, expanding geriatric population, and solid prospects of oral care products.

Global Mouth Ulcer Treatment Market Competition

Besides Colgate Palmolive Company, Bristol-Myers Squibb Company, GlaxoSmithKline, plc, and Pfizer Inc., the competitive analysis section of the global mouth ulcers treatment market covers Dr. Reddy's, 3M, Blistex Inc., Patterson Dental Supply, Inc., Church & Dwight Co, Inc., and Prince Care Pharma Private Limited as well. These brands have been subject to detailed strategic and financial profiling with an intent to reveal the exclusive actionable insights that would aid potential market participants. Significant players continue to focus on innovative product launches, affordable treatment alternatives, and faster outcome while they leverage advanced technology.